<http://schema.org/description>
"Ariad Pharmaceuticals&amp;#39; performance is an eye opener, but it complements a series of moves we&amp;#39;ve seen in the past year, all of which provide good learning lessons. "^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2013/10/10/are-you-playing-a-dangerous-biotech-valuation-game.aspx>